NEUROPATHY, AGRANULOCYTOSIS, AND HEPATO-TOXICITY FOLLOWING IMIPRAMINE THERAPY
Abstract
Bilateral peroneal nerve palsy, agranulocytosis, and hepato-toxicity following imipramine administration, with improvement after cessation of the drug, were observed. Laboratory tests seemed to rule out other possible sources of the symptoms noted. The 5 previously reported cases of motor neuropathy appearing during imipramine therapy are similar in that they all involved elderly persons, and were restricted to the lower extremities. Complete remission of neurologic symptoms is not universal. Considering recent experience with thalidomide, the large variety of neurotoxic side effects seen with imipramine would merit caution in the use of this agent in pregnancy.
Access content
To read the fulltext, please use one of the options below to sign in or purchase access.- Personal login
- Institutional Login
- Sign in via OpenAthens
- Register for access
-
Please login/register if you wish to pair your device and check access availability.
Not a subscriber?
PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.
Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).